Abstract:We used transcranial magnetic stimulation (TMS) to measure motor cortex inhibition and excitation in children with and without Tourette syndrome, testing for potential diagnostic differences and dimensional symptom‐severity associations. Although children with and without Tourette syndrome did not differ in TMS‐evoked inhibition and excitation, within Tourette syndrome, reduced motor cortex inhibition was robustly associated with increased tic, but not premonitory urge severity. This suggests a role for aberrant motor cortex inhibition in increased tic severity in children with Tourette syndrome. Aim To compare transcranial magnetic stimulation (TMS)‐derived measures of primary motor cortex (M1) physiology between children with and without Tourette syndrome, and to dimensionally analyze TMS measures with Tourette syndrome‐related symptom severity. Method We used a cross‐sectional experimental design. Sixty 8‐ to 12‐year‐old children participated (30 with Tourette syndrome: three females, mean age 10 years 10 months, standard deviation [SD] 1 year 3 months; 30 typically developing children: seven females, mean age 10 years 7 months, SD 1 year 3 months). In the group with Tourette syndrome, 15 (one female, mean age 10 years 11 months, SD 1 year 3 months) had comorbid attention‐deficit/hyperactivity disorder (ADHD), rated with the Conners, Third Edition and the parent‐reported ADHD rating scales. Tic severity was rated with the Yale Global Tic Severity Scale and urge severity with the Individualized Premonitory Urge for Tics Scale. M1 short‐interval cortical inhibition (SICI) and intracortical facilitation were compared between diagnostic groups and, within the group with Tourette syndrome, correlated with symptom severity using linear mixed‐effects models for repeated measures. Results Accounting for ADHD, we found no difference in SICI or intracortical facilitation in those with Tourette syndrome versus typically developing children (p > 0.1). In the group with Tourette syndrome, reduced M1 SICI predicted greater total (p = 0.012) and global (p = 0.002) tic severity. There were no associations with urge severity (p > 0.5). Interpretation Reduced M1 SICI is robustly associated with increased tic, but not urge, severity.

Transcranial Magnetic Stimulation at 1 Hertz Improves Clinical Symptoms in Children with Tourette Syndrome for at Least 6 Months.

Transcranial magnetic stimulation at 1Hertz improves clinical symptoms in children with Tourette syndrome for at least 6 months

Effects of Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Bilateral Parietal Cortex in Patients With Tourette Syndrome

Transcranial Magnetic and Direct Current Stimulation in Children

Bilateral transcranial magnetic stimulation of the supplementary motor area in children with Tourette syndrome

Randomized Sham Controlled Double-blind Trial of Repetitive Transcranial Magnetic Stimulation for Adults With Severe Tourette Syndrome

Application of Repetitive Transcranial Magnetic Stimulation in Tourette Syndrome

Transcranial Magnetic Stimulation in Tourette Syndrome: A Historical Perspective, Its Current Use and the Influence of Comorbidities in Treatment Response

Efficacy of repetitive transcranial magnetic stimulation for Tourette syndrome: A systematic review and meta-analysis

Targeted Interventions in Tourette’s using Advanced Neuroimaging and Stimulation (TITANS): study protocol for a double-blind, randomised controlled trial of transcranial magnetic stimulation (TMS) to the supplementary motor area in children with Tourette’s syndrome

A meta-analysis of transcranial magnetic stimulation in Tourette syndrome

Effects of 1hz Repetitive Transcranial Magnetic Stimulation on Autism with Intellectual Disability: A Pilot Study.

Repetitive Transcranial Magnetic Stimulation Modulates Long-Range Functional Connectivity in Autism Spectrum Disorder.

Biomarkers of tic severity in children with Tourette syndrome: Motor cortex inhibition measured with transcranial magnetic stimulation

Abnormal Individualized Functional Connectivity: A Potential Stimulation Target for Pediatric Tourette Syndrome

Clinical Efficacy of Different Frequency Repetitive Transcranial Magnetic Stimulation for Tardive Dyskinesia

Transcranial Magnetic Stimulation in Autism Spectrum Disorders: Neuropathological Underpinnings and Clinical Correlations.

Transcranial Magnetic Stimulation Therapy in Spastic Cerebral Palsy Children Improves Motor Activity

Clinical effects of repetitive transcranial magnetic stimulation combined with atomoxetine in the treatment of attention-deficit hyperactivity disorder

Repetitive transcranial magnetic stimulation modulates cortical-subcortical connectivity in sensorimotor network

Impact of repetitive transcranial magnetic stimulation on the directed connectivity of autism EEG signals: a pilot study